瑞納智能(301129.SZ):今年公司會繼續推進棗莊AI供熱項目
格隆匯6月12日丨瑞納智能(301129.SZ)召開線上會議,問答環節中,就“AI供熱領域業務如何展望?”
公司回覆稱,今年公司會繼續推進棗莊AI供熱項目,同時在一些省會級城市也會持續跟蹤和洽談,爭取有更多的AI項目能夠落地。
目前大型熱力公司必須走AI供熱這條路,未來市場需求一定會呈現快速增長態勢。目前熱力公司出於謹慎及資金等方面的考慮會選擇藉助有技術實力和資金實力的供應商投資,幫助其完成AI項目的實施,這必然會加快公司開拓該類業務的速度。
公司已有多個熱力公司做過AI前期的實驗和鋪墊,取得了令人滿意的效果,比傳統的自動化和信息化技術要更領先的,因此市場信心也會越來越強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.